Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer

Clinical trial NCT06928389 · RECRUITING

Trial details

NCT number: NCT06928389
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-07-08
Primary completion: 2027-05-01
Enrollment: 536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.